NOXXON Provides Update on NOX-A12 Clinical Programs

BERLIN–(COMMERCIAL THREAD) – Regulatory news: NOXXON Pharma SA (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), today provided an update on the clinical development and timelines of its core asset NOX-A12. As NOX-A12 recently reported promising data from the second …

Read More »

CHECK: Are you getting a fourth raise check?

Social media reports claiming that a fourth stimulus has already been approved and started to be available in late July are simply false. INDIANAPOLIS – Congress has already approved three separate rounds of stimulus payments during the pandemic. But will there soon be a fourth stimulus check appearing in your …

Read More »